FNDC5 and diabetes mellitus: In an in vitro experiment exploring diabetes complicated with vascular diseases, it reported that irisin can inhibit ROS-NLRP3 inflammasome signaling, thereby slowing down the process of diabetes-related endothelial inflammation and other impairment (70).